TCRT icon

Alaunos Therapeutics

124 hedge funds and large institutions have $241M invested in Alaunos Therapeutics in 2019 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership:

9% less funds holding

Funds holding: 137124 (-13)

57% less first-time investments, than exits

New positions opened: 10 | Existing positions closed: 23

67% less funds holding in top 10

Funds holding in top 10: 31 (-2)

Holders
124
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.96M
Puts
$5.23M
Net Calls
Net Calls Change

Top Buyers

1 +$17.3M
2 +$6.76M
3 +$1.74M
4
State Street
State Street
Massachusetts
+$1.43M
5
Rafferty Asset Management
Rafferty Asset Management
New York
+$806K

Top Sellers

1 -$8.16M
2 -$1.42M
3 -$1.19M
4
UBS Group
UBS Group
Switzerland
-$1.14M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$991K
Name Holding Trade Value Shares
Change
Change in
Stake
76
$107K
77
$99K
78
$97K
79
$91K
80
$88.7K
81
$88K
82
$86K
83
$79K
84
$76K
85
$73K
86
$73K
87
$68K
88
$61K
89
$58K
90
$55K
91
$54K
92
$48K
93
$44K
94
$43.3K
95
$42K
96
$40K
97
$39K
98
$39K
99
$39K
100
$39K